Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

What’s New in Prevention Epicenter Research

The CDC funded Prevention Epicenters are dedicated to advancing prevention research toward CDC’s goal to eliminate Healthcare Associated Infections. Read about the current progress being made toward that goal as we spotlight Multicenter Prevention Epicenter Projects and Preliminary Research Findings presented at ID Week.

Spotlight on Multi-Center Projects

  • MRSA Project: The REDUCE MRSA project is a cluster randomized trial designed to assess the comparative effectiveness of three principal strategies for the prevention of MRSA+ clinical cultures in intensive care units. This study is a collaborative effort of the CDC Prevention Epicenters, Agency for Healthcare Research and Quality (AHRQ), and the Hospital Corporation of America. REDUCE MRSA is a unique clinical study that was conceived out of Prevention Epicenters research. Conducting the study on a larger scale was made possible through partnership with AHRQ.
  • Streamlined Surveillance for Ventilator-Associated Pneumonia: Reducing Burden and Demonstrating Preventability (sVAP) Project: Ventilator-associated pneumonia (VAP) is a common and morbid complication of mechanical ventilation. Efforts to accurately characterize the prevalence of VAP and drive improvements have been hampered by limitations of the current surveillance definition. A new streamlined surveillance defintion (sVAP) has been shown to be objective, efficient, and a potent predictor of patient outcomes but the feasibility of using this definition for routine operational surveillance in diverse settings and the capacity of the definition to reflect meaningful improvements in patient care have not yet been evaluated. A prospective, multicenter comparison of conventional versus sVAP surveillance to determine the feasibility and clinical significance of streamlined surveillance in diverse settings under operational conditions is under way. One aim of this multicenter study is to evaluate the impact of an opt-out protocol for daily sedative interruptions and spontaneous breathing trails on conventional and sVAP rates. Check ‘What’s New’ in January 2013 for the roll-out of the Wake Up & Breathe Collaborative page.

Top of page

Spotlight on Preliminary Research Findings

Researchers from the 5 Prevention Epicenters will be presenting their findings on Health Care Associated Prevention Research at ID Week 2012, October 16-21st in San Diego California. ID Week 2012, Advancing Science-Improving Care, will feature the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases across the lifespan. Click the links below to view full abstracts developed from the latest Prevention Epicenter research.

Methicillin-Resistant Staphylococcus Aureus (MRSA)

Top of page

Multi-Drug Resistant Organisms

Top of page

Surgical Site Infections

Top of page

Ventilator Associated Pneumonia

Blood Stream Infections

Technology and Surveillance

Top of page

Coming in 2013

  • Wake Up & Breathe Collaborative and Protocol
  • 2013 Prevention Epicenter Peer-Reviewed Articles
  • And much more

Top of page

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #